1970
DOI: 10.1055/s-0028-1096803
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Insulin Release by Endogeneous Insulin in Vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1971
1971
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…Previous studies indicated that insulin inhibits its own glucose-stimulated secretion when a static incubation system is used 51,52 . The extent of inhibition seems to be related to the number of islets incubated 53 . In contrast, islets that were loaded into a dynamic perifusion system do not show a secretory downregulation through ambient insulin 54 even when seeded at a density of 4,000 islets per cm 2(55) .…”
Section: Discussionmentioning
confidence: 95%
“…Previous studies indicated that insulin inhibits its own glucose-stimulated secretion when a static incubation system is used 51,52 . The extent of inhibition seems to be related to the number of islets incubated 53 . In contrast, islets that were loaded into a dynamic perifusion system do not show a secretory downregulation through ambient insulin 54 even when seeded at a density of 4,000 islets per cm 2(55) .…”
Section: Discussionmentioning
confidence: 95%
“…Grodsky and his co-workers (1968) found no suppressive effect of the bonito insulin on the insulin secretion from rat pancreas. However, an inhibition of the insulin release from the pancreas by insulin in vitro was demonstrated by Sodoyez et al (1969), Hahn and Michael (1970), and Iversen (1971). Since in our study the plasma insulin area increased by the treatment with bonito insulin, it seems unlikely that bonito insulin euppresses the secretion of insulin from the pancreas.…”
Section: Methodsmentioning
confidence: 59%
“…The possibility of feed-back inhibiton of insulin secretion by insulin itself has been the subjects of considerable controversy (Schatz and Pfeiffer, 1977;Hahn and Michael, 1970;Liljenquist et al, 1978;Shima et al, 1977;Zilker et al, 1977;Beischer et al, 1978;Tanaka et al, 1980). Glucose-induced endogenous insulin secretion was significantly reduced during the glucose-controlled insulin infusion by means of the Biostator.…”
Section: Discussionmentioning
confidence: 99%